M&A Deal Summary |
|
|---|---|
| Date | 2024-08-20 |
| Target | Endotronix |
| Sector | Medical Products |
| Buyer(s) | Edwards |
| Sellers(s) | EQT Life Sciences |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1958 |
| Sector | Medical Products |
| Employees | 15,800 |
| Revenue | 5.4B USD (2024) |
Edwards is focused on technologies that treat structural heart disease and critically ill patients. The Company is engaged in the development and commercialization of heart valve therapies. Edwards was founded in 1958 and is based in Irvine, California.
| DEAL STATS | # |
|---|---|
| Overall | 15 of 15 |
| Sector: Medical Products M&A | 12 of 12 |
| Type: Add-on Acquisition M&A Deals | 9 of 9 |
| State: Illinois M&A | 1 of 1 |
| Country: United States M&A | 11 of 11 |
| Year: 2024 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-07-24 |
JenaValve Technology
Irvine, California, United States JenaValve Technology specializes in developing transcatheter aortic valves that can be implanted via the femoral vein or an incision between two ribs. JenaValve Technology was founded in 2006 and is based in Irvine, California. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 3.5B EUR |
| Size | Large |
| Type | Sector Focused |
EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 10 |
| Sector: Medical Products M&A | 3 of 3 |
| Type: Add-on Acquisition M&A Deals | 6 of 7 |
| State: Illinois M&A | 1 of 1 |
| Country: United States M&A | 3 of 4 |
| Year: 2024 M&A | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-08-08 |
Lumeon
Boston, Massachusetts, United States Lumeon enables healthcare organizations to orchestrate and automate systems and processes, bringing situational awareness to care operations to deliver high-performance, team-centered healthcare. Lumeon Care Pathway Management (CPM) platform and suite of solutions empower health organizations to take control of their end-to-end care delivery model and maximize the use of resources. Lumeon was founded in 2005 and is based in Boston, Massachusetts. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-09-16 |
VarmX
Leiden, Netherlands VarmX is a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation. VarmX was founded in 2016 and is based in Leiden, Netherlands. |
Sell | $2.2B |
